How Do We Address Noncommunicable Disease? Lessons Learned from the Global Health Partnerships Program
June 2nd, 2011
by
Mark Spires
| and |
Atiya Weiss
|
These authors from Johns Hopkins Bloomberg School of Public Health and Pfizer Inc, respectively, discuss what has been learned thus far from this program funded by Pfizer and the Pfizer Foundation. Noncommunicable diseases have become an important global health concern—they account for 60 percent of all deaths worldwide, or about 35 million deaths, a year with... Read the rest of this entry »
